{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T04:03:19Z","timestamp":1754193799129},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiol Ther"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s40119-023-00312-x","type":"journal-article","created":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T14:03:56Z","timestamp":1681308236000},"page":"261-274","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical Decision Pathway for the Use of Fondaparinux in the Management of Acute Coronary Syndrome (ACS) in Hospitals with and Without Catheter Laboratories: An Expert Opinion from India"],"prefix":"10.1007","volume":"12","author":[{"given":"Saumitra","family":"Ray","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bharat","family":"Shivdasani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jagdish Chander","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. T.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jagdish","family":"Hiremath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajiv","family":"Karnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhupen","family":"Desai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hemant","family":"Madan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajeev","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johann","family":"Christopher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,12]]},"reference":[{"issue":"3","key":"312_CR1","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.ihj.2014.03.009","volume":"66","author":"U Kaul","year":"2014","unstructured":"Kaul U, Sethi KK, Dalal J, et al. A multicentre retrospective study to understand anti-platelet treatment patterns and outcomes of acute coronary syndrome patients in India (TRACE). Indian Heart J. 2014;66(3):334\u20139. https:\/\/doi.org\/10.1016\/j.ihj.2014.03.009.","journal-title":"Indian Heart J"},{"key":"312_CR2","doi-asserted-by":"publisher","unstructured":"Khan MY, Ponde CK, Kumar V, Gaurav K. Fondaparinux: a cornerstone drug in acute coronary syndromes. World J Cardiol. 2022;14(1):40\u201353. https:\/\/doi.org\/10.4330\/wjc.v14.i1.40.","DOI":"10.4330\/wjc.v14.i1.40"},{"key":"312_CR3","unstructured":"Kumar R, Singh MC, Singh MC, et al. Urbanization and coronary heart disease: a study of urban\u2013rural differences in northern India. Indian Heart J. 2006;58(2):126\u201330."},{"issue":"2","key":"312_CR4","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1093\/eurheartj\/ehs219","volume":"34","author":"PP Mohanan","year":"2013","unstructured":"Mohanan PP, Mathew R, Harikrishnan S, et al. Presentation, management, and outcomes of 25 748 acute coronary syndrome admissions in Kerala, India: results from the Kerala ACS Registry. Eur Heart J. 2013;34(2):121\u20139. https:\/\/doi.org\/10.1093\/eurheartj\/ehs219.","journal-title":"Eur Heart J"},{"key":"312_CR5","unstructured":"Swanson R, Fraulini A. Rural CV service line challenges and the cardiac catheterization lab: optimizing constrained resources. Cath Lab Digest. 2014;22(6). https:\/\/www.hmpgloballearningnetwork.com\/site\/cathlab\/articles\/rural-cv-service-line-challenges-cardiac-catheterization-lab-optimizing-constrained-resourc. Accessed 31 May 2022."},{"issue":"2","key":"312_CR6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.15420\/icr.2017:26:1","volume":"13","author":"EN Onwordi","year":"2018","unstructured":"Onwordi EN, Gamal A, Zaman A. Anticoagulant therapy for acute coronary syndromes. Interv Cardiol. 2018;13(2):87\u201392. https:\/\/doi.org\/10.15420\/icr.2017:26:1.","journal-title":"Interv Cardiol"},{"issue":"9622","key":"312_CR7","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/S0140-6736(08)60623-6","volume":"371","author":"D Xavier","year":"2008","unstructured":"Xavier D, Pais P, Devereaux PJ, et al. Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data. The Lancet. 2008;371(9622):1435\u201342. https:\/\/doi.org\/10.1016\/S0140-6736(08)60623-6.","journal-title":"The Lancet"},{"key":"312_CR8","unstructured":"Akbar H, Foth C, Kahloon RA, Mountfort S. Acute ST elevation myocardial infarction. In: StatPearls. Treasure Island: StatPearls Publishing; 2022. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK532281\/. Accessed 22 June 2022."},{"key":"312_CR9","unstructured":"Basit H, Malik A, Huecker MR. Non ST segment elevation myocardial infarction. In: StatPearls. Treasure Island: StatPearls Publishing; 2022. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK513228\/. Accessed 22 June 2022."},{"issue":"Suppl","key":"312_CR10","first-page":"19","volume":"59","author":"LC Daga","year":"2011","unstructured":"Daga LC, Kaul U, Mansoor A. Approach to STEMI and NSTEMI. J Assoc Physicians India. 2011;59(Suppl):19\u201325.","journal-title":"J Assoc Physicians India"},{"issue":"6","key":"312_CR11","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1136\/hrt.2003.020321","volume":"90","author":"KAA Fox","year":"2004","unstructured":"Fox KAA. Management of acute coronary syndromes: an update. Heart. 2004;90(6):698\u2013706. https:\/\/doi.org\/10.1136\/hrt.2003.020321.","journal-title":"Heart"},{"key":"312_CR12","unstructured":"Coven DL. Acute coronary syndrome treatment & management: approach considerations, pharmacologic anti-ischemic therapy, pharmacologic antithrombotic therapy. Published online October 17, 2021. https:\/\/emedicine.medscape.com\/article\/1910735-treatment. Accessed 11 July 2022."},{"issue":"11","key":"312_CR13","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","volume":"361","author":"L Wallentin","year":"2009","unstructured":"Wallentin L, Becker RC, Budaj A, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361(11):1045\u201357. https:\/\/doi.org\/10.1056\/NEJMoa0904327.","journal-title":"N Engl J Med"},{"issue":"5","key":"312_CR14","doi-asserted-by":"publisher","first-page":"605","DOI":"10.2217\/14796678.1.5.605","volume":"1","author":"JJ Ferguson","year":"2005","unstructured":"Ferguson JJ. Clopidogrel plus aspirin in patients with acute myocardial infarction treated with fibrinolytic therapy\u2013CLARITY-TIMI 28. Future Cardiol. 2005;1(5):605\u201310. https:\/\/doi.org\/10.2217\/14796678.1.5.605.","journal-title":"Future Cardiol"},{"issue":"9748","key":"312_CR15","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/S0140-6736(10)61088-4","volume":"376","author":"SR Mehta","year":"2010","unstructured":"Mehta SR, Tanguay JF, Eikelboom JW, et al. Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial. The Lancet. 2010;376(9748):1233\u201343. https:\/\/doi.org\/10.1016\/S0140-6736(10)61088-4.","journal-title":"The Lancet"},{"key":"312_CR16","doi-asserted-by":"publisher","unstructured":"Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007;357(20):2001\u201315. https:\/\/doi.org\/10.1056\/nejmoa0706482. Accessed 13 Mar 2023.","DOI":"10.1056\/nejmoa0706482"},{"issue":"10","key":"312_CR17","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1345\/aph.1M136","volume":"43","author":"AB Blackmer","year":"2009","unstructured":"Blackmer AB, Oertel MD, Valgus JM. Fondaparinux and the management of heparin-induced thrombocytopenia: the journey continues. Ann Pharmacother. 2009;43(10):1636\u201346. https:\/\/doi.org\/10.1345\/aph.1M136.","journal-title":"Ann Pharmacother"},{"key":"312_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12909-015-0504-1","volume":"16","author":"C Ferguson","year":"2016","unstructured":"Ferguson C, Inglis SC, Newton PJ, Middleton S, Macdonald PS, Davidson PM. Education and practice gaps on atrial fibrillation and anticoagulation: a survey of cardiovascular nurses. BMC Med Educ. 2016;16:9. https:\/\/doi.org\/10.1186\/s12909-015-0504-1.","journal-title":"BMC Med Educ"},{"issue":"13","key":"312_CR19","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1001\/jama.295.13.joc60038","volume":"295","author":"S Yusuf","year":"2006","unstructured":"Yusuf S, Mehta SR, Chrolavicius S, et al. Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial. JAMA. 2006;295(13):1519\u201330. https:\/\/doi.org\/10.1001\/jama.295.13.joc60038.","journal-title":"JAMA"},{"issue":"14","key":"312_CR20","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1056\/NEJMoa055443","volume":"354","author":"S Yusuf","year":"2006","unstructured":"Yusuf S, Mehta SR, Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators, et al. Comparison of fondaparinux and enoxaparin in acute coronary syndromes. N Engl J Med. 2006;354(14):1464\u201376. https:\/\/doi.org\/10.1056\/NEJMoa055443.","journal-title":"N Engl J Med"},{"issue":"3","key":"312_CR21","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1093\/eurheartj\/ehm616","volume":"29","author":"RJG Peters","year":"2008","unstructured":"Peters RJG, Joyner C, Bassand JP, et al. The role of fondaparinux as an adjunct to thrombolytic therapy in acute myocardial infarction: a subgroup analysis of the OASIS-6 trial. Eur Heart J. 2008;29(3):324\u201331. https:\/\/doi.org\/10.1093\/eurheartj\/ehm616.","journal-title":"Eur Heart J"},{"key":"312_CR22","doi-asserted-by":"publisher","unstructured":"Dalal J, Mohan JC, Sathe S, et al. Evaluation of effectiveness and tolerability of fondaparinux in the management of symptomatic acute coronary syndrome: a real-world evidence-based study on an Indian population. Cardiol Ther. 2022;11(1):129\u201341. https:\/\/doi.org\/10.1007\/s40119-022-00253-x.","DOI":"10.1007\/s40119-022-00253-x"},{"issue":"7","key":"312_CR23","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1001\/jama.2015.517","volume":"313","author":"K Szummer","year":"2015","unstructured":"Szummer K, Oldgren J, Lindhagen L, et al. Association between the use of fondaparinux vs low-molecular-weight heparin and clinical outcomes in patients with non-ST-segment elevation myocardial infarction. JAMA. 2015;313(7):707\u201316. https:\/\/doi.org\/10.1001\/jama.2015.517.","journal-title":"JAMA"},{"key":"312_CR24","doi-asserted-by":"publisher","unstructured":"De Caterina R, Husted S, Wallentin L, et al. Parenteral anticoagulants in heart disease: current status and perspectives (section II): position paper of the ESC Working Group on Thrombosis\u2014Task Force on Anticoagulants in Heart Disease. Thromb Haemost. 2013;109(05):769\u201386. https:\/\/doi.org\/10.1160\/TH12-06-0403.","DOI":"10.1160\/TH12-06-0403"},{"key":"312_CR25","doi-asserted-by":"publisher","unstructured":"Collet JP, Thiele H, Barbato E, et al. 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J. 2021;42(14):1289\u2013367. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa575.","DOI":"10.1093\/eurheartj\/ehaa575"},{"key":"312_CR26","doi-asserted-by":"publisher","unstructured":"Gulati M, Levy PD, Mukherjee D, et al. 2021 AHA\/ACC\/ASE\/CHEST\/SAEM\/SCCT\/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;144:e368\u2013e454. doi:https:\/\/doi.org\/10.1161\/CIR.0000000000001029","DOI":"10.1161\/CIR.0000000000001029"},{"key":"312_CR27","doi-asserted-by":"publisher","unstructured":"Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes. Circulation. 2014;130(25):e344\u2013426. https:\/\/doi.org\/10.1161\/CIR.0000000000000134.","DOI":"10.1161\/CIR.0000000000000134"},{"key":"312_CR28","doi-asserted-by":"publisher","unstructured":"O\u2019Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction. Circulation. 2013;127:e362\u2013e425. https:\/\/doi.org\/10.1161\/CIR.0b013e3182742cf6. Accessed 18 Aug 2022.","DOI":"10.1161\/CIR.0b013e3182742cf6"},{"key":"312_CR29","unstructured":"Ibanez B, James S, Agewall S, et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2017;39:119\u2013177.  https:\/\/academic.oup.com\/eurheartj\/article\/39\/2\/119\/4095042. Accessed 18 Aug 2022"},{"issue":"18","key":"312_CR30","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1016\/j.jacc.2007.07.042","volume":"50","author":"SR Mehta","year":"2007","unstructured":"Mehta SR, Granger CB, Eikelboom JW, et al. Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial. J Am Coll Cardiol. 2007;50(18):1742\u201351. https:\/\/doi.org\/10.1016\/j.jacc.2007.07.042.","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"312_CR31","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.jacc.2007.02.027","volume":"49","author":"SV Manoukian","year":"2007","unstructured":"Manoukian SV, Feit F, Mehran R, et al. Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial. J Am Coll Cardiol. 2007;49(12):1362\u20138. https:\/\/doi.org\/10.1016\/j.jacc.2007.02.027.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"312_CR32","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.acvd.2014.09.009","volume":"108","author":"A Cohen","year":"2015","unstructured":"Cohen A, Stellbrink C, Le Heuzey JY, et al. SAfety of Fondaparinux in transoesophageal echocardiography-guided Electric cardioversion of Atrial Fibrillation (SAFE-AF) study: a pilot study. Arch Cardiovasc Dis. 2015;108(2):122\u201331. https:\/\/doi.org\/10.1016\/j.acvd.2014.09.009.","journal-title":"Arch Cardiovasc Dis"},{"issue":"3","key":"312_CR33","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/s11239-011-0613-6","volume":"32","author":"JCJ Sun","year":"2011","unstructured":"Sun JCJ, Teoh KHT, Sheth T, et al. Randomized trial of fondaparinux versus heparin to prevent graft failure after coronary artery bypass grafting: the Fonda CABG study. J Thromb Thrombolysis. 2011;32(3):378\u201385. https:\/\/doi.org\/10.1007\/s11239-011-0613-6.","journal-title":"J Thromb Thrombolysis"}],"container-title":["Cardiology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40119-023-00312-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40119-023-00312-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40119-023-00312-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T10:44:27Z","timestamp":1684925067000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40119-023-00312-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,12]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["312"],"URL":"https:\/\/doi.org\/10.1007\/s40119-023-00312-x","relation":{},"ISSN":["2193-8261","2193-6544"],"issn-type":[{"value":"2193-8261","type":"print"},{"value":"2193-6544","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,12]]},"assertion":[{"value":"22 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}